Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hider

Showing results (161-170 of 688) with videos related to

Pageof 69
Sort By:
The New Zealand Medical Journal|June 13, 2001
Frequent attenders at Christchurch Hospital's emergency departmentP E Helliwell, P N Hider, M W Ardagh
Pharmaceuticals (Basel, Switzerland)|September 20, 2019
The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary-Ironing out the BrainRobert R Crichton, Roberta J Ward, Robert C Hider
Seminars in Hematology|April 1, 1990
Update on the hydroxypyridinone oral iron-chelating agentsJ B Porter, R C Hider, E R Huehns
The Biochemical Journal|June 1, 1983
The effect of counterions on melittin aggregationA S Tatham, R C Hider, A F Drake
The Biochemical Journal|May 27, 2015
Design of novel fluorescent mitochondria-targeted peptides with iron-selective sensing activityVincenzo Abbate, Olivier Reelfs, Robert C Hider, et al.
Cancer Research|September 1, 1992
Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell linesK P Hoyes, R C Hider, J B Porter
JAMA Health Forum|April 25, 2025
Carbon Emissions and Bundled Payments-Expanding the Reach of Value-Based CareAhmad M Hider, Thomas C Tsai, Nicholas L Berlin
Medical Care|April 13, 2013
The mismeasurement of quality by readmission rate: how blunt is too blunt an instrument?: a quantitative bias analysisJuliet Rumball-Smith, Tony Blakely, Diana Sarfati, et al.
The British Journal of Nutrition|February 1, 1994
Absorption of iron from ferric hydroxypyranone complexesD G Maxton, R P Thompson, R C Hider
European Journal of Medicinal Chemistry|September 18, 2007
Basic 3-hydroxypyridin-4-ones: potential antimalarial agentsLotfollah S Dehkordi, Zu D Liu, Robert C Hider
Pageof 69

Showing results (161-170 of 688) with videos related to

Sort By:
Pageof 69
The New Zealand Medical Journal|June 13, 2001
Frequent attenders at Christchurch Hospital's emergency departmentP E Helliwell, P N Hider, M W Ardagh
Pharmaceuticals (Basel, Switzerland)|September 20, 2019
The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary-Ironing out the BrainRobert R Crichton, Roberta J Ward, Robert C Hider
Seminars in Hematology|April 1, 1990
Update on the hydroxypyridinone oral iron-chelating agentsJ B Porter, R C Hider, E R Huehns
The Biochemical Journal|June 1, 1983
The effect of counterions on melittin aggregationA S Tatham, R C Hider, A F Drake
The Biochemical Journal|May 27, 2015
Design of novel fluorescent mitochondria-targeted peptides with iron-selective sensing activityVincenzo Abbate, Olivier Reelfs, Robert C Hider, et al.
Cancer Research|September 1, 1992
Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell linesK P Hoyes, R C Hider, J B Porter
JAMA Health Forum|April 25, 2025
Carbon Emissions and Bundled Payments-Expanding the Reach of Value-Based CareAhmad M Hider, Thomas C Tsai, Nicholas L Berlin
Medical Care|April 13, 2013
The mismeasurement of quality by readmission rate: how blunt is too blunt an instrument?: a quantitative bias analysisJuliet Rumball-Smith, Tony Blakely, Diana Sarfati, et al.
The British Journal of Nutrition|February 1, 1994
Absorption of iron from ferric hydroxypyranone complexesD G Maxton, R P Thompson, R C Hider
European Journal of Medicinal Chemistry|September 18, 2007
Basic 3-hydroxypyridin-4-ones: potential antimalarial agentsLotfollah S Dehkordi, Zu D Liu, Robert C Hider
Pageof 69